105 related articles for article (PubMed ID: 515769)
21. Accuracy and clinical utility of dialysis dose measurement using online ionic dialysance.
Katopodis KP; Hoenich NA
Clin Nephrol; 2002 Mar; 57(3):215-20. PubMed ID: 11924753
[TBL] [Abstract][Full Text] [Related]
22. Clearance of cardiovascular medications during hemodialysis.
Tieu A; Leither M; Urquhart BL; Weir MA
Curr Opin Nephrol Hypertens; 2016 May; 25(3):257-67. PubMed ID: 27023840
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin hemodialysis: Clearance differences between high-flux hemodialysis and on-line hemodiafiltration.
Rodríguez N; Gómez M; Rico N; María Campistol J; Maduell F
Artif Organs; 2019 Mar; 43(3):261-269. PubMed ID: 30302764
[TBL] [Abstract][Full Text] [Related]
24. Effects of chronic renal failure and hemodialysis on the monoethylglycinexylidide liver function test.
Palatini P; Floreani M; Padrini R; Piccoli P; Bertoli M; Calò L; Orlando R
Clin Chem; 2000 Sep; 46(9):1406-8. PubMed ID: 10973873
[No Abstract] [Full Text] [Related]
25. Extracorporeal pump assistance--novel treatment for acute lidocaine poisoning.
Freedman MD; Gal J; Freed CR
Eur J Clin Pharmacol; 1982; 22(2):129-35. PubMed ID: 7094983
[TBL] [Abstract][Full Text] [Related]
26. Comparison of high-flux hemodialysis with hemodialysis filtration in treatment of uraemic pruritus: a randomized controlled trial.
Jiang X; Ji F; Chen ZW; Huang QL
Int Urol Nephrol; 2016 Sep; 48(9):1533-41. PubMed ID: 27379625
[TBL] [Abstract][Full Text] [Related]
27. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
Válek A; Sulková S; Laurinová Z
Ter Arkh; 1991; 63(6):89-93. PubMed ID: 1948757
[No Abstract] [Full Text] [Related]
28. FHD: an index to evaluate drug elimination by hemodialysis.
Launay-Vacher V; Izzedine H; Baumelou A; Deray G
Am J Nephrol; 2005; 25(4):342-51. PubMed ID: 15980618
[TBL] [Abstract][Full Text] [Related]
29. Baclofen toxicity in patients with severely impaired renal function.
Chen KS; Bullard MJ; Chien YY; Lee SY
Ann Pharmacother; 1997 Nov; 31(11):1315-20. PubMed ID: 9391686
[TBL] [Abstract][Full Text] [Related]
30. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.
Samolsky Dekel BG; Donati G; Vasarri A; Croci Chiocchini AL; Gori A; Cavallari G; Di Nino G; Mercolini L; Protti M; Mandrioli R; Melotti RM; La Manna G
Pain Pract; 2017 Jun; 17(5):604-615. PubMed ID: 27589376
[TBL] [Abstract][Full Text] [Related]
31. Assessment of hemodialysis adequacy by ionic dialysance: comparison to standard method of urea removal.
Racki S; Zaputović L; Maleta I; Grzetić M; Mavrić Z; Devcić B; Vujicić B
Ren Fail; 2005; 27(5):601-4. PubMed ID: 16153000
[TBL] [Abstract][Full Text] [Related]
32. Hemodialysis of mefenamic acid in uremic patients.
Wang LH; Lee CS; Marbury TC
Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
[TBL] [Abstract][Full Text] [Related]
33. [Urea distribution volume calculated by ionic dialysance].
Teruel JL; Merino JL; Fernández-Lucas M; Tenorio MT; Rivera M; Marcén R; Ortuño J
Nefrologia; 2006; 26(1):121-7. PubMed ID: 16649433
[TBL] [Abstract][Full Text] [Related]
34. In-vivo and in-vitro hemodialysis studies of thiocyanate.
Pahl MV; Vaziri ND
J Toxicol Clin Toxicol; 1982 Nov; 19(9):965-74. PubMed ID: 7182524
[TBL] [Abstract][Full Text] [Related]
35. How to determine ionic dialysance for the online assessment of delivered dialysis dose.
Di Filippo S; Manzoni C; Andrulli S; Pontoriero G; Dell'Oro C; La Milia V; Bacchini G; Crepaldi M; Bigi MC; Locatelli F
Kidney Int; 2001 Feb; 59(2):774-82. PubMed ID: 11168961
[TBL] [Abstract][Full Text] [Related]
36. Topical capsaicin therapy for uremic pruritus in patients on hemodialysis.
Makhlough A; Ala S; Haj-Heydari Z; Kashi Z; Bari A
Iran J Kidney Dis; 2010 Apr; 4(2):137-40. PubMed ID: 20404425
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of ofloxacin in severe chronic renal failure.
Bandai H; Tsubakihara Y; Yamato E; Yokoyama K; Okada N; Nakanishi I; Iida N
Clin Ther; 1989; 11(2):210-8. PubMed ID: 2736567
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system and cardiac manifestations of hydrochlorothiazide overdosage; treatment with hemodialysis.
Zahid M; Krumlovsky FA; Roxe D; del Greco F; Mistovich M
Am J Kidney Dis; 1988 Jun; 11(6):508-11. PubMed ID: 3376934
[TBL] [Abstract][Full Text] [Related]
39. Busulfan clearance in renal failure and hemodialysis.
Ullery LL; Gibbs JP; Ames GW; Senecal FM; Slattery JT
Bone Marrow Transplant; 2000 Jan; 25(2):201-3. PubMed ID: 10673681
[TBL] [Abstract][Full Text] [Related]
40. Ionic dialysance allows an adequate estimate of urea distribution volume in hemodialysis patients.
Di Filippo S; Manzoni C; Andrulli S; Pontoriero G; Dell'Oro C; La Milia V; Tentori F; Crepaldi M; Bigi MC; Locatelli F
Kidney Int; 2004 Aug; 66(2):786-91. PubMed ID: 15253734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
